Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311805![]() (7-(4-Fluorophenyl)-8-(7-chloro-1H-indazol-5-yl)-2-...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311771![]() (2-Cyclopentyl-7-(4-fluorophenyl)-8-(7-methyl-1H-in...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292056![]() (2-Cyclobutyl-3-(7-methyl-1H-indazol-5-yl)-5-(trifl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292057![]() (3-(7-Chloro-1H-indazol-5-yl)-2-cyclobutyl-5-(trifl...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311766![]() (2-Cyclobutyl-7-(4-fluorophenyl)-8-(7-methyl-1H-ind...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311848![]() (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311811![]() (7-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-2-(triflu...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311806![]() (7-(4-Fluorophenyl)-8-(7-methyl-1H-indazol-5-yl)-2-...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311808![]() (2-(Difluoromethyl)-7-(4-fluorophenyl)-8-(7-methyl-...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292055![]() (7-Chloro-5-(2-cyclobutyl-5-(trifluoromethyl)-2H-py...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311847![]() (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292054![]() (5-(2-Cyclobutyl-5-(trifluoromethyl)-2H-pyrazolo[4,...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292053![]() (3-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-5-(triflu...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311768![]() (7-Cyclopentyl-8-(7-methyl-1H-indazol-5-yl)-2-(trif...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311810![]() (2-Cyclopropyl-7-(4-fluorophenyl)-8-(7-methyl-1H-in...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311828![]() (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311849![]() (2-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(triflu...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292061![]() (5-(Difluoromethyl)-2-isopropyl-3-(7-methyl-1H-inda...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311829![]() (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-7-(trif...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292037![]() (2-Cyclopentyl-3-(7-methyl-1H-indazol-5-yl)-5-(trif...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311799![]() (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311843![]() (3-Chloro-8-(7-chloro-1H-indazol-5-yl)-2-cyclopropy...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311845![]() (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311792![]() (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-7-(trif...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292065![]() (5,7-Bis(difluoromethyl)-2-isopropyl-3-(7-methyl-1H...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311833![]() (8-(7-Chloro-1H-indazol-5-yl)-7-isopropyl-2-(triflu...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311793![]() (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311781![]() (8-(7-Chloro-1H-indazol-5-yl)-2,7-bis(trifluorometh...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311767![]() (6-(7-(4-Fluorophenyl)-2-(trifluoromethyl)-[1,2,4]t...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311850![]() (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292051![]() (7-Chloro-5-(2-isopropyl-5-(trifluoromethyl)-2H-pyr...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292052![]() (2-Isopropyl-3-(7-methyl-1H-indazol-5-yl)-5-(triflu...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311830![]() (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292045![]() (3-(7-Chloro-1H-indazol-5-yl)-2-methyl-5-(trifluoro...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311783![]() (5-(2,7-Bis(trifluoromethyl)-[1,2,4]triazolo[1,5-a]...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311775![]() (8-(7-Chloro-1H-indazol-5-yl)-2,7-bis(trifluorometh...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311769![]() (7-(Azetidin-1-yl)-8-(7-methyl-1H-indazol-5-yl)-2-(...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311754![]() (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311844![]() (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-3-fluor...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311834![]() (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311831![]() (7-Chloro-5-[2-cyclopropyl-7-(trifluoromethyl)imida...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311824![]() (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311785![]() (8-(7-Chloro-1H-indazol-5-yl)-7-(difluoromethyl)-2-...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292062![]() (7-Chloro-5-(5-(difluoromethyl)-2-isopropyl-2H-pyra...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311796![]() (8-(7-Chloro-1H-indazol-5-yl)-2-ethyl-7-(trifluorom...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311851![]() (2-Ethyl-8-(7-methyl-1H-indazol-5-yl)-7-(trifluorom...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292050![]() (5-(2-Isopropyl-5-(trifluoromethyl)-2H-pyrazolo[4,3...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311776![]() (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292049![]() (3-(7-Chloro-1H-indazol-5-yl)-2-ethyl-5-(trifluorom...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311846![]() (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB Reactome pathway UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 127 total ) | Next | Last >> |